Psoriatic Arthritis News

CHICAGO — Rheumatologists should make greater efforts to collaborate with ophthalmologists to better care for patients with inflammatory and systemic eye diseases such as uveitis and scleritis, according to Jim T. Rosenbaum, MD, chief of the division of arthritis and rheumatic diseases at Oregon Health & Science University.

CHICAGO — Nail enthesitis potentially offers an “intriguing gateway” connecting the appendicular system to the skeletal manifestations of psoriatic arthritis, according to a presenter at the 2019 Interdisciplinary Autoimmune Summit.

CHICAGO — Although rarely taken into account in practice guidelines, patient satisfaction remains an important factor in both treatment adherence and outcomes for psoriatic and rheumatoid arthritis, according to Jon T. Giles, MD, MPH, of the Columbia University College of Physicians and Surgeons.

There is no substantial difference in the risks for atrial fibrillation and major adverse cardiovascular events between ustekinumab and TNF inhibitors among patients with psoriatic arthritis or psoriasis, according to data published in JAMA Dermatology.

Primary care patients with inflammatory disease, particularly those with early-onset disease, demonstrate elevated rates of depression and anxiety, according to data published in the Annals of the Rheumatic Diseases.

Faced with an increasing incidence and prevalence of autoimmune disease in the United States —approximately 23.5 million Americans are affected across the country, according to the NIH — Bonnie Feldman, MBA, DDS, says it is time to acknowledge what she calls “an invisible epidemic.”

Etanercept alone, or in combination with methotrexate, has greater efficacy than methotrexate monotherapy in patients with psoriatic arthritis, both in terms of ACR20 and minimal disease activity responses, as well as radiographic progression, according to recent study findings.

Among patients with psoriatic arthritis with pre-existing enthesitis or dactylitis, 90-mg treatments of ixekizumab, administered either every 2 or 4 weeks, significantly improved both conditions, according to data published in Arthritis Research & Therapy.

SCOTTSDALE, Ariz. — Due to the diversity of its expression, psoriatic arthritis is not often able to take full advantage of treatments for similar inflammatory arthritides or psoriasis, according to a presentation here.

SCOTTSDALE, Ariz. — Despite various options, there is a similar safety profile across JAK inhibitors, according to an expert at the Annual Basic and Clinical Immunology for the Busy Clinician symposium.